Vivitrol Kit
Product Images NDC 65757-300

Product Visual Gallery

This gallery contains 18 technical images submitted to the FDA as part of the official labeling for Vivitrol (NDC 65757-300). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alkermes, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure A (Viv03 0048 01)

Illustration of the VIVITROL kit contents including administration and preparation needles. The diagram labels a vial of VIVITROL microspheres, a diluent vial, a prepackaged syringe, administration needles in sizes 1.5 inch and 2 inch with needle protection devices, and a 1 inch preparation needle for suspension preparation.*

FDA Label Image

Figure B (Viv03 0048 02)

An instructional illustration showing the preparation steps for a medication kit. The images depict hands removing a blue cap from a vial, then drawing liquid into a syringe from the vial, indicating aseptic technique for medication administration.*

FDA Label Image

Figure C (Viv03 0048 03)

An instructional illustration showing a hand holding a vial labeled as part of a medication kit, with a syringe being inserted into the vial to withdraw liquid. This image is likely part of the preparation steps for the VIVITROL naltrexone injection kit by Alkermes, Inc.*

FDA Label Image

Figure D (Viv03 0048 04)

An instructional illustration showing a hand holding a small vial with a blue cap. The image includes an arrow indicating a back-and-forth motion, suggesting how to handle or shake the vial. It is likely part of usage or preparation instructions for VIVITROL kit by Alkermes, Inc.*

FDA Label Image

Figure E (Viv03 0048 05)

An instructional illustration showing a person drawing liquid from a vial into a syringe. The vial contains a blue-colored solution, and a close-up inset focuses on the vial neck and needle insertion. The image is likely part of the preparation steps for administering VIVITROL (naltrexone) injection.*

FDA Label Image

Figure F (Viv03 0048 06)

An instructional illustration showing a two-handed technique for assembling or manipulating a syringe and vial. The image includes directional arrows indicating rotational movements for properly attaching or securing the syringe to the vial. No text or branding visible.*

FDA Label Image

Figure G (Viv03 0048 07)

An instructional illustration showing two steps of preparing an injection. The left panel depicts a hand attaching a needle to a vial, and the right panel shows drawing the liquid from the vial into a syringe. This relates to the VIVITROL kit containing naltrexone.*

FDA Label Image

Figure H (Viv03 0048 08)

An instructional illustration showing a gloved hand administering an injection with a syringe into the upper arm of a patient. Highlighted areas on the arm indicate the injection site, demonstrating proper intramuscular injection technique for the VIVITROL kit by Alkermes, Inc.*

FDA Label Image

Figure I (Viv03 0048 09)

An instructional diagram showing a hand holding a syringe with the needle cap being removed, indicated by a downward arrow. This image is part of the usage instructions for VIVITROL (naltrexone) kit by Alkermes, Inc.*

FDA Label Image

Figure J (Viv03 0048 10)

An instructional illustration showing a hand holding a syringe with the needle pointed outward. The image appears to be a step in a procedural guide related to VIVITROL kit use.*

FDA Label Image

Naltrexone Structural Formula (Viv03 0048 11)

Chemical structure of naltrexone, the active ingredient in VIVITROL, shown as a molecular diagram with labeled atoms and bonds representing its chemical composition.*

FDA Label Image

Figure 1 (Viv03 0048 12)

A line graph comparing the percent of patients over percent of opioid-free weeks between Vivitrol (n=126) and placebo (n=124) groups. The vertical axis shows percent of patients, and the horizontal axis shows percent of opioid-free weeks. The Vivitrol group is represented by a green solid line with filled circles, and the placebo group by a blue dashed line with open circles. The graph indicates a higher percentage of patients remaining opioid-free over time in the Vivitrol group compared to placebo.*

FDA Label Image

Package Label- Principal Display Panel-vivitrol® Commercial Kit Carton (Viv03 0048 13)

Packaging label for VIVITROL 380 mg/vial kit, an injectable suspension of naltrexone for extended-release. The label includes instructions for reconstitution, storage conditions, and contents of the kit. Manufactured and marketed by Alkermes, Inc., the label also displays the NDC barcode and highlights that the product is for gluteal intramuscular injection only, available by prescription only.*

FDA Label Image

Package Label- Principal Display Panel-vivitrol ®microspheres Vial Label (Viv03 0048 14)

Label for VIVITROL microspheres, 380 mg per vial, an extended-release injectable suspension of naltrexone. It highlights that the product is for gluteal intramuscular injection only and must be reconstituted with the provided diluent before use. Each mL contains 95 mg naltrexone. The label includes storage instructions, manufacturer Alkermes, Inc. Waltham, MA, and an NDC barcode.*

FDA Label Image

Package Label- Principal Display Panel-vivitrol® Diluent Vial Label (Viv03 0048 15)

Label for a diluent vial for use only with VIVITROL microspheres, 4 mL per vial. The diluent contains carboxymethylcellulose sodium, polysorbate 20, sodium chloride, sodium hydroxide, and hydrochloric acid in water for injection. It is a single-dose vial labeled not for direct administration and advises refrigeration storage. Manufactured by Alkermes, Inc.*

FDA Label Image

Package Label- Principal Display Panel-vivitrol®sample Kit Carton (Viv03 0048 16)

Packaging label for Vivitrol 380 mg/vial kit, an extended-release injectable suspension of naltrexone by Alkermes, Inc. The label includes instructions for intramuscular injection, storage temperatures, and kit contents. The box prominently displays 'Sample - Not for Resale' and contains multiple panels with dosage, manufacturer, and prescribing information.*

FDA Label Image

Package Label- Principal Display Panel- Sample Vivitrol®microspheres Vial Label (Viv03 0048 17)

Label for Vivitrol microspheres, 380 mg/vial (naltrexone for extended-release injectable suspension) by Alkermes, Inc. The label indicates it is a sample not for sale and specifies use for gluteal intramuscular injection only. Instructions note reconstitution with enclosed diluent prior to administration and refrigeration storage at 2°C to 8°C (36°F to 46°F). It is a single-dose vial with directions to discard unused portions.*

FDA Label Image

Package Label- Principal Display Panel- Sample Vivitrol®diluent Vial Label (Viv03 0048 18)

Label for VIVITROL diluent vial, 4 mL, for use only with VIVITROL microspheres. The label states this is a single-dose vial and sample not for sale. It includes storage instructions to refrigerate at 2°C to 8°C and cautions not for direct administration. Manufactured by Alkermes, Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.